Last reviewed · How we verify
Yasmin Regulatory Post Marketing Surveillance
The objective of this Post Marketing Surveillance (PMS) is to gain information about safety and efficacy in real practice.
Details
| Lead sponsor | Bayer |
|---|---|
| Status | COMPLETED |
| Enrolment | 777 |
| Start date | 2007-12 |
| Completion | 2013-08 |
Conditions
- Contraception
Interventions
- EE30/DRSP (Yasmin, BAY86-5131)
Primary outcomes
- Safety and efficacy in real practice — After 6 cycle of treatment
Countries
South Korea